← Back to headlines
David Einhorn Trims Stakes in Teva and Kyndryl
Investor David Einhorn's firm has reportedly trimmed its holdings in Teva Pharmaceutical Industries Limited and Kyndryl Holdings Inc. This move suggests a strategic reduction in exposure to these two companies.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
